Newsletter SignupSearch

Proceedings from the State of the Science Summit on Post-Traumatic Stress Disorder

Announcing the Proceedings from the State of the Science Summit on Post-Traumatic Stress Disorder. The inaugural State of the Science Summit explored the state of the science in diagnosis of trauma-related brain disorders with a major focus on PTSD.

Proceedings from the State of the Science Summit
on Post-Traumatic Stress Disorder

Announcing the Inaugural State of the Science Summit Proceedings

Cohen Veterans Bioscience is leading the development, advocacy and implementation of a Brain Trauma Blueprint (BTB) to help guide development efforts and accelerate the progression towards a new generation of precision diagnostics and targeted therapeutics for trauma related brain disorders. The development of the Brain Trauma Blueprint is facilitated through a series of State of the Science Summits (SOSS) that fosters collaboration across a multidisciplinary stakeholder community of academia, government, industry, military and research.

The inaugural SoSS explored the state of the science in diagnosis of trauma-related brain disorders with a major focus on PTSD. Working groups surveyed the current scientific landscape, identified knowledge gaps, and considered new evidence-based scientific and clinical models to fill these gaps. The outcome will be a prioritized list of specific recommendations that addresses the identified knowledge gaps across PTSD, with dissemination to legislators, public and private funding organizations, academia, researchers, industry and the public to inform the next generation of translational research. The Consensus Document will be shared later this year.

[sf_button colour=”accent” type=”standard” size=”standard” link=”https://www.cohenveteransbioscience.org/wp-content/uploads/2016/10/SOSS1-Conference-Proceedings.pdf” target=”_blank” icon=”” dropshadow=”yes” extraclass=”donateheader”]Download the Inaugural State of the Science Summit Proceedings[/sf_button]

Share this article:

More from CVB

American Brain Coalition Selects Cohen Veterans Bioscience Executive as New Board Member

New Artificial-Intelligence-based Tools for Monitoring Parkinson’s Disease using Wearable Devices

Peter Hoehn, Accomplished Pharmaceutical Executive, Joins Cohen Veterans Bioscience (CVB) in Newly Created Executive Leadership Role

About Cohen Veterans Bioscience (CVB)

Cohen Veterans Bioscience is a non-profit 501(c)(3) biomedical research and technology organization dedicated to advancing brain health by fast-tracking precision diagnostics and tailored therapeutics.